Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
a study on Huntington's Disease
Huntington's Disease, Huntington Disease, Juvenile Huntington's Disease, Registry, Cohort, CHDI
Lead Scientist at UCSF
- Michael Geschwind
Dr. Geschwind received his M.D.and Ph.D. in neuroscience through the National Institutes of Health (NIH)-sponsored Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine in New York.
- accepting new patients
- Start Date
- Completion Date
- CHDI Foundation, Inc.
- Study Type
- Observational [Patient Registry]
- Expecting 20000 study participants
- Last Updated